Researchers at the Center for Infectious Disease Research at the University of Washington in Seattle, in conjunction with the Fred Hutchison Cancer Research Center, have developed a vaccine that uses the entire malaria-causing parasite — called P. falciparum — to stimulate a protective immune response.
Source: tatoeba (12258660)